Table 1.
Template | Strategy | Monomer | Crosslinker | Particle Size Diameter | Year | Ref. |
---|---|---|---|---|---|---|
Salicylic acid and acetylsalicylic acid | Non-covalent | DEGDMA | - | 1.7 μm | 2006 | [22] |
Propranolol | Non-covalent | MAA | DVB | 100 nm | 2006 | [23] |
Boc-l-tryptophan | Non-covalent | NIPAAm | EGDMA | micron-sized | 2010 | [24] |
Flufenamic acid | Non-covalent | MAA NIPAAm |
EGDMA | micron-sized | 2011 | [25] |
Ibuprofen | Non-covalent | DMAEMA | EGDMA | ~1 μm | 2011 | [26] |
Bisphenol A | Non-covalent | MAA, FMMA |
EGDMA | micron-sized | 2012, 2018 | [18,46] |
Bisphenol A | Semi-covalent | BPADM | EGDMA | micron-sized | 2012 | [18] |
Aspirin and Acetaminophen | Non-covalent | MAA 4-Vpy MMA |
EGDMA | 250–300 nm | 2013 | [30] |
Bisphenol A and 2,4-dichlorophenoxyacetic acid |
Non-covalent | MAA | EGDMA | 300 nm | 2013 | [34] |
Carbamazepine | Non-covalent | MAA | EGDMA | 200 nm | 2013 | [35] |
Labdanolic acid | Non-covalent | DMAEMA | EGDMA | micron-sized | 2014 | [38] |
DBTSO2 | Non-covalent | MAA | EGDMA | micron-sized | 2014 | [40] |
Gallic acid | Non-covalent | MAA MMA |
EGDMA | 150–200 nm | 2016 | [41] |
Acetamide | Non-covalent | MAA and MAM, ITA and HEMA |
EGDMA | 3.4–5.3 μm | 2017 | [43,47] |